263 filings
Page 3 of 14
8-K
39qcohvsr
4 Aug 22
Results of Operations and Financial Condition
7:01am
8-K
9nzivlra
27 Jun 22
ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development
4:12pm
8-K
2sdyk swon84w
10 May 22
ESSA Pharma Provides Corporate Update and Reports Financial Results for Clinical and Corporate Highlights
7:07am
8-K
3b0xmf1y
10 Mar 22
Submission of Matters to a Vote of Security Holders
10:52am
S-8
fy5bigf0zq
1 Oct 21
Registration of securities for employees
4:15pm
S-3ASR
qn5m vo0rohvrvfp1c
21 Jun 21
Automatic shelf registration
3:31pm
8-K
zkdly8u2vvwr
31 Mar 21
ESSA Announces Change to its Board of Directors
12:00am
8-K
owe6xxknyp5v3e03cm8y
2 Mar 21
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
m8wgv c7lly1hh
22 Feb 21
Other Events
5:16pm
424B5
2n2bk2y7wv8l
18 Feb 21
Prospectus supplement for primary offering
4:58pm
8-K
ht0sq6faxe
16 Feb 21
ESSA Pharma Provides Corporate Update and Reports Financial Results for Recent Clinical and Corporate Highlights
12:00am
424B5
8205mn25zh3not
16 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
sffordz2
11 Feb 21
Other Events
10:28am
10-Q
vcsxob0c
11 Feb 21
Quarterly report
7:02am